J Skin Stem Cell

Image Credit:J Skin Stem Cell

Bleomycin Tatooing for Periungual Verruca

Author(s):
Sweta Hasmukh RambhiaSweta Hasmukh RambhiaSweta Hasmukh Rambhia ORCID1,*
1Just Care Dental and Skin Clinic, Mumbai, India

Journal of Skin and Stem Cell:Vol. 10, issue 4; e143299
Published online:Dec 16, 2023
Article type:Letter
Received:Nov 25, 2023
Accepted:Dec 04, 2023
How to Cite:Rambhia SH. Bleomycin Tatooing for Periungual Verruca. J Skin Stem Cell. 2023;10(4):e143299. doi: https://doi.org/10.5812/jssc-143299

Dear Editor,
I am writing to draw attention to the challenges posed by periungual verruca, a viral infection affecting the periungual area, which presents both aesthetic and functional difficulties. Traditional treatments, including Co2 Laser, cryotherapy, and surgery, often encounter issues of recurrence and potential damage to the nail. The injection of bleomycin or its use with a derma roller has been employed traditionally, but these methods can be painful and cumbersome, particularly in the periungual area (1).
In response to these challenges, we propose the use of bleomycin tattooing as an innovative approach to periungual verruca treatment. This method involves creating repeated micro-punctures using a single tattoo needle (refer to Figure 1), followed by immersion in a 3% Bleomycin solution until slight pinpoint bleeding occurs. The technique is not only convenient and easy to use but has shown remarkable efficacy, with resolution of the lesion observed after a single session (see Figure 2).
Tatooing Device Used
Figure 1.

Tatooing Device Used

Before and After
Figure 2.

Before and After

While mild pain may be a potential side effect, it is generally well-tolerated and short-lived when compared to the potential benefits. Proper technique and thorough patient selection are crucial for achieving optimal results.
In conclusion, Bleomycin tattooing emerges as an economical and effective option for periungual verruca treatment, effectively addressing existing limitations associated with traditional modalities. By harnessing bleomycin's immunomodulatory properties, this method promises sustained and effective clearance of periungual warts.

Footnotes

References

  • 1.
    Al-Naggar MR, Al-Adl AS, Rabie AR, Abdelkhalk MR, Elsaie ML. Intralesional bleomycin injection vs microneedling-assisted topical bleomycin spraying in treatment of plantar warts. J Cosmet Dermatol. 2019;18(1):124-8. [PubMed ID: 29687566]. https://doi.org/10.1111/jocd.12537.

Similar Articles

15
May
2014

Efficacy of Intralesional Bleomycin in the Treatment of Resistant Warts

Mir-Hadi Aziz-Jalali,
Gholamhossein Ghafarpour,
Mohammad Reza Rezaei,
Ashkan Heshmatzadeh Behzadi,
Masoumeh Rohani Nasab,
Mohammad Ali Nilforoushzadeh

Aziz-Jalali M, Ghafarpour G, Rezaei MR, Heshmatzadeh Behzadi A, Rohani Nasab M, et al. Efficacy of Intralesional Bleomycin in the Treatment of Resistant Warts. J Skin Stem Cell. 2014;1(1):e18875. doi: https://doi.org/10.17795/jssc18875

27
Nov
2017

Bleomycin Chemotherapy for Oral Leukoplakia

Shishir Ram Shetty,
Sura Ali Ahmed Foud Al- Bayati,
Ahmed Atef Shon

Ram Shetty S, Ali Ahmed Foud Al- Bayati S, Atef Shon A. Bleomycin Chemotherapy for Oral Leukoplakia. Int J Cancer Manag. 2017;10(11):e7900. doi: https://doi.org/10.5812/ijcm.7900

15
Feb
2021
J Skin Stem Cell

Surgical Pearl: Disposable Hypodermic Needle Punch

Muhammed Mukhtar

Mukhtar M. Surgical Pearl: Disposable Hypodermic Needle Punch. J Skin Stem Cell. 2020;7(4):e106408. doi: https://doi.org/10.5812/jssc.106408

23
Jun
2015

Comparative Study of the Therapeutic Effects of Topical Mometasone Furoate 0.1% Plus Tretinoin 0.05% and Topical Mometasone Furoate 0.1% Plus Eucerin in the Treatment of Vitiligo

Elham Behrangi,
Abbas Rasi,
Faezeh Jannati,
Parvin Jannati,
Farzaneh Beigmohammadi,
Zahra Azizian

Behrangi E, Rasi A, Jannati F, Jannati P, Beigmohammadi F, et al. Comparative Study of the Therapeutic Effects of Topical Mometasone Furoate 0.1% Plus Tretinoin 0.05% and Topical Mometasone Furoate 0.1% Plus Eucerin in the Treatment of Vitiligo. J Skin Stem Cell. 2015;2(2):e30410. doi: https://doi.org/10.17795/jssc30410

29
Sep
2024
J Skin Stem Cell

A Case Report of Microifusion of Drugs Into the Skin (MMP®) with Minoxidil in Chronic Telogen Effluvium

Adriana de Carvalho Corrêa,
Carla Jorge Machado,
Sueli Carneiro

Corrêa ADC, Machado CJ, Carneiro S. A Case Report of Microifusion of Drugs Into the Skin (MMP®) with Minoxidil in Chronic Telogen Effluvium. J Skin Stem Cell. 2024;11(3):e153565. doi: https://doi.org/10.5812/jssc-153565


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC